Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma

William W. Busse, Pierluigi Paggiaro, Xavier Muñoz, Thomas B. Casale, Mario Castro, G. Walter Canonica, Jo A. Douglass, Yuji Tohda, Nadia Daizadeh, Benjamin Ortiz, Nami Pandit-Abid

Source: Eur Respir J, 58 (4) 2004605; 10.1183/13993003.04605-2020
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
William W. Busse, Pierluigi Paggiaro, Xavier Muñoz, Thomas B. Casale, Mario Castro, G. Walter Canonica, Jo A. Douglass, Yuji Tohda, Nadia Daizadeh, Benjamin Ortiz, Nami Pandit-Abid. Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma. Eur Respir J, 58 (4) 2004605; 10.1183/13993003.04605-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: